Aterian (NASDAQ:ATER) Announces Quarterly Earnings Results

Aterian (NASDAQ:ATER) announced its quarterly earnings data on Friday. The company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.17) by $0.12, FiscalAI reports. The company had revenue of $0.01 million during the quarter, compared to analyst estimates of $20.30 million. Aterian had a negative return on equity of 82.05% and a negative net margin of 39.56%.

Aterian Price Performance

NASDAQ:ATER traded up $0.02 during trading hours on Friday, hitting $0.50. The stock had a trading volume of 128,523 shares, compared to its average volume of 1,951,772. The company has a 50 day simple moving average of $0.98 and a two-hundred day simple moving average of $0.85. The firm has a market capitalization of $5.44 million, a price-to-earnings ratio of -0.19 and a beta of 0.78. Aterian has a one year low of $0.35 and a one year high of $1.87.

Hedge Funds Weigh In On Aterian

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Susquehanna International Group LLP raised its holdings in shares of Aterian by 310.2% in the 3rd quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock valued at $43,000 after acquiring an additional 30,637 shares in the last quarter. Citadel Advisors LLC increased its position in shares of Aterian by 222.0% in the third quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock worth $35,000 after purchasing an additional 22,865 shares during the last quarter. XTX Topco Ltd purchased a new stake in Aterian in the second quarter valued at approximately $55,000. Finally, Goldman Sachs Group Inc. lifted its position in Aterian by 73.0% during the first quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock valued at $45,000 after purchasing an additional 9,026 shares during the last quarter. 7.02% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the stock. Wall Street Zen cut shares of Aterian from a “hold” rating to a “sell” rating in a research note on Saturday, July 25th. Weiss Ratings upgraded Aterian from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Tuesday, May 19th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company has an average rating of “Sell”.

Aterian Company Profile

Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.

Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.